Comment

Comment by Dr. Krishna Kumari Challa 9 hours ago

Nearly 3,000 peer-reviewed medical papers have fake citations, AI-assisted audit finds
An AI-assisted audit of 2.5 million biomedical papers identified 4,046 fake citations across 2,810 papers, with the rate of fake references increasing over 12-fold since 2023, particularly after mid-2024. Most affected papers had not received publisher action. Recommendations include mandatory reference verification, enhanced metadata, systematic tracking, and retroactive screening to maintain research integrity.
A new Columbia University School of Nursing AI-assisted audit reveals nearly 3,000 peer-reviewed medical papers have fake citations that do not exist in scientific databases. The results highlight an alarming trend in academic publishing as the use of AI grows.
The research letter, "Fabricated citations: an audit across 2·5 million biomedical papers," is published in The Lancet. (Research letters published in the Correspondence section include research findings and are externally peer-reviewed. Unlike Articles containing original data, research letters are shorter and the research they contain is usually preliminary, exploratory, or reporting on early findings.)

To conduct their analysis, the research team developed an automated verification system using AI that scanned 2.5 million papers published from January 1, 2023, to February 18, 2026, in PubMed Central's Open Access.

Among 97.1 million verified references, they identified 4,046 fake citations across 2,810 papers. The rate has grown more than 12-fold since 2023, with the sharpest increase beginning mid-2024, coinciding with the rise of AI writing tools.

This discovery directly impacts patients as medical professionals make treatment decisions based on clinical guidelines.
A medical professional or clinical guideline developer has no way of knowing that the evidence they are relying on does not exist. For example, one paper we reviewed had 18 out of 30 fake references. Some of those citations are already being cited by other papers and appear in systematic reviews that inform clinical care.
Based on their findings, the authors recommend publishers verify references with each paper submission. They also recommend that indexing services add metadata to records so that users can assess the accuracy of references.

Lastly, the research team urges major research integrity databases to establish a dedicated category for fake references to enable systematic tracking and accountability. They call on publishers to retroactively screen existing publications and issue corrections or retractions where fake references compromise a paper's conclusions. Notably, at the time of the audit, 98.4% of affected papers had not received any publisher action.

Maxim Topaz et al, Fabricated citations: an audit across 2·5 million biomedical papers, The Lancet (2026). DOI: 10.1016/s0140-6736(26)00603-3

Howard Bauchner et al, Fabricated references: a new threat to editorial integrity, The Lancet (2026). DOI: 10.1016/s0140-6736(26)00798-1

**

Comment by Dr. Krishna Kumari Challa 9 hours ago

This everyday plant protein may be quietly reshaping blood pressure risk in ways doctors cannot ignore
Higher intake of legumes (up to 170 g/day) and soy foods (60–80 g/day) is associated with a 16–19% lower risk of developing high blood pressure, with risk reduction plateauing beyond these amounts. The evidence suggests a probable causal relationship, potentially due to the potassium, magnesium, fiber, and isoflavones in these foods. Variability in study methods and definitions limits certainty, but findings support dietary recommendations to increase legume and soy consumption for blood pressure management.
And the optimal daily amount may be around 170 g of legumes, which include peas, lentils, chickpeas and beans, and 60 to 80 g of soy foods, examples of which include tofu, soy milk, edamame, tempeh, and miso, the findings indicate.

Legume and soy consumption and the risk of hypertension: a systematic review and dose–response meta-analysis of prospective studies, BMJ Nutrition Prevention & Health (2026). DOI: 10.1136/bmjnph-2025-001449

Comment by Dr. Krishna Kumari Challa 9 hours ago

Multiple man-made 'forever chemicals' found in 98.5% of people tested
PFAS, a group of persistent man-made chemicals, were detected in 98.8% of over 10,500 blood samples, with most individuals carrying multiple types. The most common combination included five PFAS, such as PFOS and PFOA, found in 26.1% of samples. These findings underscore widespread, combined PFAS exposure and highlight the need for mixture-based risk assessment.
One of the PFAS most commonly detected in this new study (in 97.9% of samples) was perfluorohexane sulfonic acid (linear PFOA), which is already recognized as being linked to adverse health conditions—including potential impacts on the immune system, liver, and thyroid—prompting action, internationally, for its restriction.

Laura M. Labay et al, PFAS co-positivities identified in more than 10,000 serum/plasma samples, Journal of Occupational and Environmental Hygiene (2026). DOI: 10.1080/15459624.2025.2601605

Comment by Dr. Krishna Kumari Challa 11 hours ago

To understand why some duplicated genomes  persist, researchers analyzed the genomes of 470 species of flowering plants, constructing one of the largest datasets of its kind. They looked for blocks of genes that appear in almost identical pairs—a marker of past whole-genome duplication events. Then, they compared the data with information from 44 plant fossils to estimate when these duplications occurred.

Their analysis revealed a striking pattern. The researchers found that the genes that persist over time tend to originate from whole-genome duplications during major periods of environmental upheaval.

These include the asteroid-triggered mass extinction 66 million years ago, several periods of global cooling when ecosystems collapsed, and the Paleocene-Eocene Thermal Maximum (PETM) about 56 million years ago—a period of rapid global warming.

The findings help explain a long-standing puzzle of why polyploidy is common, but only a few persevere in plant genomes over millions of years.
Under these extreme conditions, polyploid plants might have gained an edge. Traits that are normally disadvantageous, such as maintaining a larger and more complex genome, can become beneficial, say the researchers.

The Rise of Polyploids During Environmental Upheaval, Cell (2026). DOI: 10.1016/j.cell.2026.04.008. www.cell.com/cell/fulltext/S0092-8674(26)00397-1

Part 2

Comment by Dr. Krishna Kumari Challa 11 hours ago

Plants survived the dinosaur-killing asteroid by duplicating genomes, study suggests

When an asteroid as big as Mount Everest struck Earth 66 million years ago, it wiped out all non-avian dinosaurs and roughly a third of life on the planet. But many plants survived the devastation. In a new study published in Cell, researchers reveal that the accidental duplications of genomes—a natural phenomenon—might have helped many flowering plants survive some of the most extreme environmental upheavals in Earth's history.

This strategy could help plants adapt to the rapid climate changes unfolding today.

Whole-genome duplication is often seen as an evolutionary dead end in stable environments. But in harsh situations, it can provide unexpected advantages.

Most organisms carry two sets of chromosomes, one from each parent. But in flowering plants, many species carry additional sets as a result of random whole-genome duplication. For example, most cultivated bananas have three sets of chromosomes while wheat plants can have as many as six, a condition known as polyploidy.
Whole-genome duplication occurs relatively frequently in plants, and it can be costly. Larger genomes require more nutrients to maintain, increase the risk of acquiring harmful mutations, and affect fertility. For these reasons, only a small fraction of duplicated genomes are retained and passed down through generations in the wild.

On the other hand, genome duplications can increase genetic variations, and genes can evolve new functions. These changes may help organisms better tolerate stress such as heat or drought.

Part 1

Comment by Dr. Krishna Kumari Challa yesterday

Anaesthetized people can process words

A deep brain structure called the hippocampus can learn and process language even when a person is under general anaesthesia. A probe that can record the activity of individual neurons in real time detected the region responding to the speech in a podcast and learning how to differentiate different tones. That doesn’t mean anaesthetized people are ‘secretly awake’ — just that this one structure, the hippocampus, computes and integrates information even under anaesthesia.

https://www.nature.com/articles/s41586-026-10448-0?utm_source=Live+...

Comment by Dr. Krishna Kumari Challa yesterday

The 'nostalgia effect': Scientists produce less disruptive work as they age
As scientists age, their work shifts from producing disruptive innovations to creating novel combinations of existing ideas, with a tendency to cite older research. This "nostalgia effect" is transmitted through academic hierarchies, influencing younger researchers and shaping the direction of entire fields and nations. Countries with younger research communities generate more disruptive science, highlighting the importance of balancing continuity with the influx of new ideas.

Haochuan Cui et al, Aging and the narrowing of scientific innovation, Science (2026). DOI: 10.1126/science.ady8732

Comment by Dr. Krishna Kumari Challa yesterday

Evidence review finds aluminum-adjuvant vaccines not tied to autism, asthma or type 1 diabetes

Current evidence does not support direct (causal) associations between aluminum-adjuvant vaccines and serious or long-term health outcomes, including autism, diabetes and asthma, finds a review of the latest data published by The BMJ.
Current evidence from randomized controlled trials and large observational studies shows no causal association between aluminum-adjuvant vaccines and serious or long-term health outcomes, including autism, type 1 diabetes, asthma, or myalgia. The most common adverse reactions are rare, localized, and self-limited injection site nodules or granulomas.
Small amounts of aluminum salts (adjuvants) are commonly used in vaccines against diphtheria, tetanus, pertussis (whooping cough), hepatitis, HPV, and meningitis to make them more effective and longer-lasting. Yet, despite a decades-long safety record, questions about potential long-term effects continue to arise in scientific and public settings.

To address this, researchers searched scientific databases to identify randomized controlled trials and observational studies published up to 27 November 2025 that assessed health outcomes after exposure to aluminum adjuvants included in vaccines.

They found 59 eligible studies that investigated a range of outcomes including autism, asthma, headache, muscle pain (myalgia), and skin reactions (nodules and granulomas) at the injection site. Studies of investigational vaccines were excluded, as their findings are not directly applicable to existing immunization programs.

The studies were of varying quality, but the researchers were able to assess their risk of bias and certainty of evidence using established tools.

High quality evidence from randomized controlled trials and large observational studies consistently showed no association between aluminum-adjuvanted vaccines and health outcomes, including autism, type 1 diabetes, asthma, and myalgia.
The most consistently documented reactions were persistent nodules or granulomas at the injection site, but they were uncommon, local, and self-limited.

Aluminium adjuvants in vaccines and potential health effects: systematic review, The BMJ (2026). DOI: 10.1136/bmj-2025-088921

Comment by Dr. Krishna Kumari Challa yesterday

Cancer cells are better able to resist treatments when they have an abnormal number of chromosomes
Cancer cells with abnormal chromosome numbers (aneuploidy) exhibit reduced levels of PARP1 protein, impairing a cell death pathway triggered by oxidative DNA damage and enhancing resistance to treatment-induced stress. This mechanism enables aneuploid cancer cells to survive and spread more effectively, with metastatic tumors showing lower PARP1 levels than primary tumors.

Pan Cheng et al, PARP1 suppression drives ROS resistance in aneuploid cancer cells, Molecular Cell (2026). DOI: 10.1016/j.molcel.2026.04.006

Comment by Dr. Krishna Kumari Challa yesterday

New study challenges the inevitability of cognitive decline and proves that brain gain is possible at any age

A study recently published in Scientific Reports reveals that cognitive decline is not an inevitable part of aging.
Longitudinal data from nearly 4,000 adults aged 19–94 show that cognitive performance can improve at any age through consistent, targeted brain-healthy practices. Gains were observed across all baseline levels, with the greatest improvements in those starting with lower scores, and no upper limit to brain health optimization was detected. Small, daily interventions correlated with higher brain health scores, and improvements were consistent across age groups, indicating that cognitive decline is not inevitable. Brain health was also shown to be resilient and trainable, even during major life stressors.
Key research findings:

No ceiling for improvement: Significant gains in brain health were observed across the board. Even top-tier performers continued to improve over 1,000 days, suggesting there is no known limit to brain optimization.
The low-starter advantage: Participants who entered the study with the lowest baseline scores demonstrated the most significant rates of improvement, demonstrating that poor brain health is not a life sentence.
Small habit changes make a big difference: Gains were directly correlated with consistency of utilization. Participants who engaged the most in 5 to 15 minutes of daily micro-training and adopted brain-healthy habits in their everyday lives achieved the highest brain health scores.
Universal potential at any age: Younger adults saw gains equal to those in their 70s and 80s, debunking the myth that proactive brain health is only for seniors.

Lori G. Cook et al, Measuring and increasing the brain health span across adulthood: a public health imperative, Scientific Reports (2026). DOI: 10.1038/s41598-026-51403-3

• ‹ Previous
• 1
• 2
• 3
• …
• 1228
• Next ›
• Page